XML Feed for RxPG News   Add RxPG News Headlines to My Yahoo!   Javascript Syndication for RxPG News

Research Health World General
 
  Home
 
 Latest Research
 Cancer
 Psychiatry
 Genetics
 Surgery
 Aging
 Ophthalmology
 Gynaecology
 Neurosciences
 Pharmacology
 Cardiology
 Obstetrics
 Infectious Diseases
 Respiratory Medicine
 Pathology
 Endocrinology
 Immunology
 Nephrology
 Gastroenterology
 Biotechnology
 Radiology
 Dermatology
 Microbiology
 Haematology
 Dental
 ENT
  Hearing Imapirment
 Environment
 Embryology
 Orthopedics
 Metabolism
 Anaethesia
 Paediatrics
 Public Health
 Urology
 Musculoskeletal
 Clinical Trials
 Physiology
 Biochemistry
 Cytology
 Traumatology
 Rheumatology
 
 Medical News
 Health
 Opinion
 Healthcare
 Professionals
 Launch
 Awards & Prizes
 
 Careers
 Medical
 Nursing
 Dental
 
 Special Topics
 Euthanasia
 Ethics
 Evolution
 Odd Medical News
 Feature
 
 World News
 Tsunami
 Epidemics
 Climate
 Business
 
 India
Search

Last Updated: Nov 18, 2006 - 12:32:53 PM

ENT Channel
subscribe to ENT newsletter

Latest Research : ENT

   DISCUSS   |   EMAIL   |   PRINT
Tonsillar homing of Epstein-Barr virus-specific CD8 T cells
Aug 19, 2005 - 1:54:00 PM, Reviewed by: Dr.

In long-term virus carriers where both lytic and latent infections have been reduced to very low levels, both types of virus-specific response are dramatically enriched in tonsils compared to blood.

 
In a study appearing online on August 18 in advance of print publication of the September 1 issue of the Journal of Clinical Investigation, Alan Rickinson and colleagues from University of Birmingham address the immunology of long-term oropharyngeal shedding of Epstein-Barr virus at a time when infection of circulating lymphocytes is well-controlled.

The authors used three groups of patients at different stages of infection, representing different positions of the virus-host balance: acute infectious mononucleosis (IM) patients undergoing primary infection, post-IM patients shortly after resolution of acute infection, and long-term asymptomatic virus carriers.

During the acute disease and shortly after its resolution, CD8+ T cells specific for virus replicative epitopes are not efficiently targeted to oropharyngeal sites of viral replication, coincident with prolonged viral shedding from these sites.

By contrast, responses to virus latent cycle epitopes begin to accumulate more quickly in the tonsil post-IM and the latent infection is more rapidly controlled. In long-term virus carriers where both lytic and latent infections have been reduced to very low levels, both types of virus-specific response are dramatically enriched in tonsils compared to blood.

Indeed, in healthy asymptomatic carriers total reactivities to defined EBV epitopes can account for up to 20% of the entire tonsillar CD8 population. The data suggest that efficient control of EBV infection requires appropriate CD8 T cell homing to oropharyngeal sites.
 

- September 1 issue of the Journal of Clinical Investigation
 

PDF of this article at: https://www.the-jci.org/article.php?id=24810

 
Subscribe to ENT Newsletter
E-mail Address:

 

AUTHOR CONTACT:
Alan Rickinson
University of Birmingham, Birmingham, UK
Phone: 44-121-414-4492; Fax: 44-121-414-4486; E-mail: [email protected]


Related ENT News

UK researcher identifies brain region responsible for spatial hearing
Boosting local immunity in nose can help treat chronic sinusitis
Acidic mammalian chitinase gene linked to recurrent sinusitis
Beta-actin mutations linked to deafness and dystonia
Role of Folic Acid in Treatment of Laryngeal Leucoplakia
Hyperactivity, attention deficit, sleepiness, and ADHD often improves after tonsillectomy - Study
New vaccine against ear infection
Middle cranial fossa approach preserves hearing in acoustic neuroma patients
Aldosterone linked to good hearing as we age
Antibiotic telithromycin linked to liver damage


For any corrections of factual information, to contact the editors or to send any medical news or health news press releases, use feedback form

Top of Page

 

© Copyright 2004 onwards by RxPG Medical Solutions Private Limited
Contact Us